Syros Pharmaceuticals, a therapeutics company harnessing breakthroughs in gene control to discover and develop revolutionary drugs to treat cancer and other diseases, announced today that Jorge Conde has joined Syros’ executive leadership team as its Chief Financial Officer (CFO) and Chief Product Officer. Mr. Conde will lead the platform strategy for Syros’ novel gene regulation technology and manage the overall finances for the company.
Help employers find you! Check out all the jobs and post your resume.
